证券代码：600666 证券简称：奥瑞德 公告编号：临2025-039 1 / 3 | 波 | | % | % | | -9- | 自转为正 | 哈尔滨市 | 绩补偿事 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | 12 | 式冻结之 | 中级人民 | 宜申请执 | | | | | | | | 日起计算 | 法院 | 行 | | | | | | | 2025 | 36 个月， | 黑龙江省 | 公司因业 | | 左洪 | 74,271,715 | 88.13 | 2.69 | 是 | -9- | 自转为正 | 哈尔滨市 | 绩补偿事 | | 波 | | % | % | | 12 | 式冻结之 | 中级人民 | 宜申请执 | | | | | | | | 日起计算 | 法院 | 行 | | 合计 | 235,423,715 | - | 8.52 | - | - | - | - | - | | | | | % | | | | | | 奥瑞德光电股份有限公司 关于持股 5%以上股东股份被轮候冻结的公告 本公司董事会及全体董事 ...

Core Viewpoint - The company plans to sell a total of 8.686 million shares of Guizhou Yibai Pharmaceutical, 970,600 shares of Aorui De, 7,716 shares of China Ping An, and 4.7122 million shares of Hunan Erkang Pharmaceutical, aiming to optimize its asset structure and improve liquidity and efficiency [1] Group 1 - The estimated profit from the sale of these stocks, after deducting costs and taxes, is expected to exceed 50% of the company's audited net profit for the last year [1] - The sale is intended to enhance the company's asset liquidity and utilization [1] - The company is strategically timing the sale based on stock market conditions [1]

Core Viewpoint - The company plans to sell a significant number of shares in various companies based on market conditions, which is expected to yield substantial profits exceeding 50% of its audited net profit from the last year [1] Group 1: Share Sales - The company intends to sell 8.686 million shares of Guizhou Yibai Pharmaceutical Co., Ltd. [1] - The company plans to sell 970,600 shares of Aorui De Optoelectronics Co., Ltd. [1] - The company will sell 7,716 shares of China Ping An Insurance (Group) Company [1] - The company aims to sell 4.7122 million shares of Hunan Erkang Pharmaceutical Co., Ltd. [1] Group 2: Financial Impact - The estimated profit from the sale of these shares, after deducting holding costs and related taxes, is projected to account for over 50% of the company's audited net profit from the previous year [1]

Core Viewpoint - The company plans to sell a significant number of shares in various companies based on market conditions, with potential gains expected to exceed 50% of its audited net profit from the last year [1] Group 1: Planned Share Sales - The company intends to sell 8.686 million shares of Yibai Pharmaceutical (600594) [1] - The company plans to sell 970,600 shares of Aorui De (600666) [1] - The company will sell 7,716 shares of China Ping An [1] - The company aims to sell 4.7122 million shares of Erkang Pharmaceutical (300267) [1] Group 2: Financial Implications - The expected gains from the share sales, after deducting holding costs and related taxes, are projected to account for over 50% of the company's audited net profit from the previous year [1] - The transaction details, including the ability to complete the sales and the specific timing and pricing, remain uncertain and will require shareholder approval [1]

证券代码：600666 证券简称：奥瑞德 公告编号：临2025-038 奥瑞德光电股份有限公司 关于持股 5%以上股东股份将被 第二次司法拍卖的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司分别于 2025 年 1 月 25 日、2025 年 2 月 26 日、2025 年 3 月 15 日、2025 年 3 月 28 日披露了《关于持股 5%以上股东股份将被司法拍卖的提示性公告》《关于持股 5%以上股东股份被司法拍卖的进展公告》《关于持股 5%以上股东股份将被第二次司法 拍卖的提示性公告》《关于持股 5%以上股东股份被第二次司法拍卖的进展公告》(公告 编号：临 2025-004、临 2025-006、临 2025-012、临 2025-014），哈尔滨市中级人民 法院立案执行江海证券有限公司与褚淑霞国内非涉外仲裁裁决一案，在"阿里拍卖·司 法"（sf.taobao.com）公开拍卖褚淑霞持有的 65,152,000 股公司股票，第一次拍卖 结果为流拍，第二次拍卖因需重新调查上市公司限制流通股 ...

Group 1 - On September 1, Aorede executed a block trade of 7.3 million shares, with a transaction amount of 26.134 million yuan, accounting for 5.67% of the total transaction amount for the day [1] - The transaction price was 3.58 yuan, which represents an 8.21% discount compared to the market closing price of 3.9 yuan [1]

Summary of Key Points Core Viewpoint - On August 29, 2023, Aored's block trading platform recorded two transactions totaling 16 million shares, with a transaction value of 60.64 million yuan, at a price of 3.79 yuan per share, reflecting a discount of 3.07% compared to the closing price of the day [2]. Trading Activity - In the last three months, Aored has seen a total of 11 block trades, accumulating a transaction value of 157 million yuan [2]. - The closing price of Aored on August 29 was 3.91 yuan, down 1.76% for the day, with a turnover rate of 4.40% and a total transaction amount of 417 million yuan [2]. - Throughout the day, there was a net outflow of 52.13 million yuan in main capital, and over the past five days, the stock has declined by 3.93% with a total net outflow of 183 million yuan [2]. Transaction Details - The block trades on August 29 included: - 10 million shares traded for 37.90 million yuan at 3.79 yuan per share, with a discount of 3.07%, facilitated by CITIC Securities and Guotai Junan Securities [2]. - 6 million shares traded for 22.74 million yuan at the same price and discount, also involving Guotai Junan Securities [2].

Group 1 - The trading date for the securities mentioned is August 29, 2025 [1] - The securities involved are 门瑞德 (Mooride) with code 600666 and 奥瑞德 (Aoride) with code 100111 [1] - The transaction price for both securities is 3.79 yuan [1] - The total transaction amount for 门瑞德 is 37.90 million yuan, with a volume of 1,000 shares [1] - The total transaction amount for 奥瑞德 is 22.74 million yuan, with a volume of 600 shares [1] Group 2 - The buying brokerage for 门瑞德 is 中信建投证券股份有限公司 (CITIC Securities) [1] - The selling brokerage for 门瑞德 is 国泰海通证券股份有限公司 (Guotai Junan Securities) [1] - The buying brokerage for 奥瑞德 is 长江证券股份有限公司 (Changjiang Securities) [1] - The selling brokerage for 奥瑞德 is also 国泰海通证券股份有限公司 (Guotai Junan Securities) [1]

Company Overview - Aorede Optoelectronics Co., Ltd. is located in Harbin, Heilongjiang Province, and was established on November 25, 1992, with its listing date on July 12, 1993 [2] - The company's main business includes the research, production, and sales of sapphire crystal materials, sapphire crystal growth equipment, and sapphire products, as well as precision processing equipment for hard and brittle materials and 3D glass bending machines [2] - The revenue composition of Aorede is as follows: computing power services 52.31%, sapphire products 39.39%, and others 8.30% [2] Financial Performance - For the first half of 2025, Aorede achieved operating revenue of 219 million yuan, a year-on-year increase of 10.12%, and a net profit attributable to shareholders of 61.39 million yuan, a year-on-year increase of 1263.22% [2] - The company has cumulatively distributed cash dividends of 82.17 million yuan since its A-share listing, with no dividends distributed in the past three years [3] Stock Market Activity - As of August 29, Aorede's stock price was 3.90 yuan per share, with a market capitalization of 10.778 billion yuan [1] - The stock has increased by 53.54% year-to-date, but has seen a decline of 4.18% in the last five trading days and 3.47% in the last twenty days [1] - Aorede has appeared on the "Dragon and Tiger List" six times this year, with the most recent appearance on August 11, where it recorded a net purchase of 52.24 million yuan [1] Shareholder Information - As of June 30, 2025, Aorede had 133,800 shareholders, an increase of 40.06% from the previous period, with an average of 18,089 circulating shares per person, a decrease of 28.60% [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the ninth largest shareholder, holding 11.4026 million shares as a new shareholder [3]

Group 1 - On August 27, a block trade of 300,000 shares of Aorede was executed, with a transaction amount of 1.155 million yuan, accounting for 0.13% of the total transaction volume for the day [1] - The transaction price was 3.85 yuan, which represents a discount of 4.23% compared to the market closing price of 4.02 yuan [1] - The buying and selling brokerage firms involved in the transaction were Shenwan Hongyuan Securities Co., Ltd. and Shenwan Hongyuan West Securities Co., Ltd. [2]